Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, William L. Dahut, Anna Couvillon et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 312
Clinical Evaluation and Biomarker Profiling of Hsp90 InhibitorsAkira Yuno, Jane B. Trepel, Min-Jung Lee et al.|Methods in molecular biology|2017Cited by 122
Rebalancing Protein Homeostasis Enhances Tumor Antigen PresentationAlex M. Jaeger, Luke Whitesell, Lauren Stopfer et al.|Clinical Cancer Research|2019Cited by 61